Table 2 Clinicopathological features of gastric cancer patients (Stratified by age)
From: Novel APC gene mutations associated with protein alteration in diffuse type gastric cancer
Parameters | Younger age group (Age ≤ 45 years) | Older age group (Age 46–79 years) | P-value |
|---|---|---|---|
Gender | |||
 Male | 06 (15%) | 16 (40%) | 0.326 |
 Female | 08 (20%) | 10 (25%) |  |
BMI (Mean ± SD) | 21.4 kg/m2 ± 3.6 | 22.1 kg/m2 ± 2.9 | 0.058 |
Tumor size (cm), (mean ± SD) | 4.6 ± 2.8 | 4.9 ± 3.1 | 0.922 |
Tumor location | |||
 Upper | 08 (20%) | 13 (32.5%) | 0.869 |
 Middle | 02 (5%) | 05 (12.5%) |  |
 Lower | 04 (10%) | 06 (15%) |  |
 Whole | 0 | 02 (5%) |  |
Type of gastrectomy | Â | Â | 0.186 |
Total | 10 (25%) | 12 (30%) | Â |
Subtotal | 04 (10%) | 14 (35%) | Â |
Stage | |||
 Stage I | 0 | 0 |  |
 Stage II | 7 (17.5%) | 12 (30%) | 0.828 |
 Stage III | 5 (12.5%) | 8 (20%) |  |
 Stage IV | 2 (5%) | 6 (15%) |  |
Abdominal pain | 9 (22.5%) | 16 (40%) | 0.161 |
Weight loss | 5 (12.5%) | 12 (30%) | 0.05 |
Hemorrhage | 7 (17.5%) | 3 (7.5%) | 0.205 |
Dysphagia | 6 (15%) | 5 (12.5%) | 0.76 |
Early satiety | 3 (7.5%) | 3 (7.5%) | 1.00 |
Vomiting | 4 (10%) | 12 (30%) | 0.045 |
Increased Abdominal girth | 1 (2.5%) | 0 | 0.317 |